Jerome H. Kim, M.D. ’84, has assumed his post as director general of the International Vaccine Institute (IVI), a non-profit based in Seoul, Korea, and dedicated to research in vaccine development and delivery for the developing world. Kim brings extensive experience and knowledge, having served as the principal deputy and chief at the Laboratory of Molecular Virology and Pathogenesis at the Military HIV Research Program. He also served as project manager for the HIV Vaccines and Advanced Concepts Evaluation Project Management Offices, U.S. Army Medical Materiel Development Activity USA.
A colonel in the United States Army Medical Corps, Kim is a leader in HIV research and HIV vaccine development. He was named one of "The 50 Most Influential People in Vaccines" in 2014 by the vaccine industry organization Vaccine Nation. He led the U.S. Army’s Phase III HIV vaccine trial (RV144), which was the first to show that an HIV vaccine could protect against infection. His research interests include HIV molecular epidemiology, host genetics, and HIV vaccine development.
The author of more than 160 publications, he received in 2013 the John Maher Award for Research Excellence from the Department of Medicine, Uniformed Services University of the Health Sciences. Under Kim's leadership, the IVI will continue on its mission to discover, develop, and deliver safe, effective, and affordable vaccines for the world's developing nations.
Kim is a professor of medicine at the Uniformed Services University of the Health Sciences and is a Fellow of the American College of Physicians and the Infectious Diseases Society of America.